10x Genomics Inc.
TXG | NASDAQ
$81.70
+$2.60 (+3.29%)
Sep 22, 2026, 1:11 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 642.82M | 610.79M | 618.73M | 516.41M | 490.49M | 298.85M |
Cost of Revenue | 198.94M | 196.3M | 209.41M | 120.39M | 74.09M | 58.47M |
Gross Profit | 443.88M | 414.48M | 409.31M | 396.02M | 416.4M | 240.38M |
Operating Income | -110.89M | -194.56M | -265.33M | -167.94M | -52.91M | -85.32M |
Interest Income | 20.05M | 18.45M | 16.91M | 6.65M | 206K | 1.53M |
Pretax Income | -39.91M | -177.7M | -248.76M | -161.97M | -53.72M | -534.48M |
Net Income | -43.54M | -182.63M | -255.1M | -166M | -58.22M | -542.73M |
Selling & General & Admin | 316.13M | 344.34M | 343.33M | 298.3M | 257.56M | 202.33M |
Research & Development | 238.63M | 264.7M | 270.33M | 265.67M | 211.75M | 123.38M |
Other Expenses | n/a | n/a | 60.98M | n/a | n/a | n/a |
Operating Expenses | 554.77M | 609.04M | 674.64M | 563.97M | 469.31M | 325.7M |
Interest Expense | n/a | 4K | 33K | 476K | 866K | 1.68M |
Selling & Marketing Expenses | n/a | 3.9M | n/a | 3.7M | 4.7M | 1.9M |
Cost & Expenses | 753.71M | 805.34M | 884.06M | 684.35M | 543.4M | 384.17M |
Income Tax Expense | 3.64M | 4.93M | 6.34M | 4.03M | 4.51M | 8.26M |
Shares Outstanding (Basic) | 124.75M | 120.45M | 117.17M | 113.86M | 110.35M | 101.15M |
Shares Outstanding (Diluted) | 124.75M | 120.45M | 117.17M | 113.86M | 110.35M | 101.15M |
EPS (Basic) | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 | -5.37 |
EPS (Diluted) | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 | -5.37 |
EBITDA | 3.91M | -133.99M | -205.11M | -128.49M | -24.6M | -513.77M |
EBIT | -39.91M | -177.7M | -248.73M | -161.5M | -52.85M | -532.79M |
Depreciation & Amortization | 43.82M | 43.71M | 43.62M | 33.01M | 28.25M | 19.02M |
Add to Watchlist
Select watchlists to add or remove TXG